About Karen Wurster
Form D filings for Adipo Therapeutics in 2024 list Karen Wurster as CEO and director.
Karen Wurster first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Karen Wurster in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Karen Wurster works with at each company, as listed on that company's latest Form D.
Adipo Therapeutics, LLC · Form D, Dec 11, 2024